My ePortfolio Register   

AACR 2014 /
Microenvironment of tumours key to cancer's progression

5th - 9th Apr 2014

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 02.05.14
Views: 2051

Dr Rakesh Jain - Harvard Medical School, Boston, USA

Dr Jain talks to ecancertv at the AACR conference about how the influence of a tumour's microenvironment is key to its progression and resistance to treatment.

Conflicts of interest

Research Grants - Dyax, MedImmune, Roche
Consultant - Noxxon, WebMD, Zyngenia
Scientific Advisory Board & Equity - Enlight, SynDevRx
Board of Directors & Equity - XTuit Pharmaceuticals
Board of Trustees - H&Q Healthcare Investors and H&Q Life Sciences Investors


· AACR 2014

Previous conferences: highlights

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

Cancer Intelligence